Behavioral Interventions to Promote Condom Use among Women Living with HIV: A Systematic Review Update

Gonçalves, T.R., Faria, E.R., Carvalho, F.T., et al.

This study updated a previous systematic review and meta-analysis (1980–2010) on behavioral interventions promoting condom use among women living with HIV. The authors broadened the previous review, including newly published studies (2010–2014). They identified recent randomized controlled trials (RCTs) or controlled studies investigating behavioral interventions that: included women living with HIV; focused on condom use promotion; presented/analyzed outcomes by gender; used a three-month follow-up or more; and considered at least one HIV-related behavioral or biological outcome. Eight studies comprising a total of 1,355 women living with HIV were included in the meta-analyses, and 13 studies were qualitatively described. The authors noted that data on how behavioral interventions affect HIV-positive women's condom use remain limited. The meta-analysis showed that behavioral interventions did not have a greater impact on consistent condom use or unprotected sex when compared to standard care or minimal support interventions. However, the qualitative syntheses showed improvements in consistent condom use and fewer unprotected sexual acts in all but one intervention. The authors suggested interpreting the findings with caution (they were based on a few small trials). They said that behavioral change interventions appear to be difficult to evaluate through RCTs and called for additional research to assess potential gains from interventions that promote safe sexual behavior.

March 10, 2017
Year of publication
behavioral interventions, condom use, HIV-positive women, women living with HIV

Similar Resources

Timely access to antiretroviral treatment (ART) is vital to ensuring safe motherhood and reducing vertical transmission. Treatment guidance and programming has changed dramatically in recent years.

Many countries are working to reduce or eliminate mother-to-child transmission (MTCT) of HIV. Prevention efforts have been conceptualized as steps in a cascade but cascade completion rates during and after pregnancy are low.

This paper documents the development of the global and national monitoring and reporting systems for PMTCT and paediatric HIV care and treatment programmes, achievements and remaining challenges.

On International Women’s Day 2017, UNAIDS released a new report, When women lead, change happens, which shows the urgent need to scale up HIV prevention and treatment services for women and girls.

Remarkable progress is being made on HIV treatment. Ahead of World AIDS Day, UNAIDS has launched a new report showing that access to treatment has risen significantly. In 2000, just 685 000 people living with HIV had access to antiretroviral therapy.

In 2013, Uganda updated its prevention of maternal-to-child transmission of HIV program to Option B+, which requires that all HIV-infected pregnant and breastfeeding women be started on lifelong antiretroviral therapy (ART) regardless of CD4 count…

Gender-based power imbalances place women at significant risk for sexual violence, however, little research has examined this association among women living with HIV/AIDS.

A new study of the impact of cytotoxic T lymphocyte (CTL) escape mutations suggests that holes in the host immune repertoire contribute to poor disease outcomes, owing to a gradual deterioration of the host anti-HIV-1 immune response.

Introduction: Women living with HIV are vulnerable to gender-based violence (GBV) before and after diagnosis, in multiple settings.

DREAMS is an ambitious $385 million partnership to reduce HIV infections among adolescent girls and young women in 10 sub-Saharan African countries. The goal of DREAMS is to help girls develop into Determined, Resilient, Empowered, AIDS-free, Mentored, and Safe women.